Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Cero Therapeutics Holdings, Inc.

Clinical trials sponsored by Cero Therapeutics Holdings, Inc., explained in plain language.

Cero Therapeutics Holdings, Inc. CERO OTC

Biotech developing cellular therapies for cancer and inflammation.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1

Engineered T-Cells take on tough blood cancers in first human trial

Disease control Recruiting now

This early-phase study tests a new treatment called CER-1236 for people with certain blood cancers (acute myeloid leukemia, myelodysplastic syndrome, or myelofibrosis) that have not responded to standard therapy. The treatment uses a patient's own immune cells, which are modified…

Phase: PHASE1 • Sponsor: CERo Therapeutics Holdings, Inc. • Aim: Disease control

Last updated Jun 27, 2026 12:01 UTC